PURPOSE: Regional brain concentrations of dopamine transporters have been examined to elucidate the neurochemical substrates of neurologic and psychiatric conditions. Many of these conditions are associated with increased (or decreased) cigarette smoking prevalence; therefore, current smoking may confound the results of these investigations. This study determined whether healthy current smokers and nonsmokers exhibit differences in dopamine transporter (DAT) binding measured by Tc-99m TRODAT SPECT. MATERIALS AND METHODS: Tc-99m TRODAT SPECT brain scans were retrospectively evaluated in 46 nonsmokers and 8 current smokers, all of whom had been recruited and screened as healthy controls for previous imaging studies. The scans were acquired approximately 3 hours after the intravenous administration of 740 MBq (20 mCi) of Tc-99m TRODAT and were reconstructed with a simple bandpass filter. Regions of interest (ROIs) were placed manually on subregions of the right and left basal ganglia and distribution volume ratios (DVRs) were compared for the smoker and nonsmoker groups. RESULTS: There were significant decreases in DAT binding in current smokers compared with nonsmokers in the caudate nuclei bilaterally, the right anterior putamen and the left posterior putamen. CONCLUSION: Reduced DAT binding in ROIs relevant to movement disorders as well as other neuropsychiatric conditions may have important implications for evaluating scans in these patient populations.
PURPOSE: Regional brain concentrations of dopamine transporters have been examined to elucidate the neurochemical substrates of neurologic and psychiatric conditions. Many of these conditions are associated with increased (or decreased) cigarette smoking prevalence; therefore, current smoking may confound the results of these investigations. This study determined whether healthy current smokers and nonsmokers exhibit differences in dopamine transporter (DAT) binding measured by Tc-99m TRODAT SPECT. MATERIALS AND METHODS: Tc-99m TRODAT SPECT brain scans were retrospectively evaluated in 46 nonsmokers and 8 current smokers, all of whom had been recruited and screened as healthy controls for previous imaging studies. The scans were acquired approximately 3 hours after the intravenous administration of 740 MBq (20 mCi) of Tc-99m TRODAT and were reconstructed with a simple bandpass filter. Regions of interest (ROIs) were placed manually on subregions of the right and left basal ganglia and distribution volume ratios (DVRs) were compared for the smoker and nonsmoker groups. RESULTS: There were significant decreases in DAT binding in current smokers compared with nonsmokers in the caudate nuclei bilaterally, the right anterior putamen and the left posterior putamen. CONCLUSION: Reduced DAT binding in ROIs relevant to movement disorders as well as other neuropsychiatric conditions may have important implications for evaluating scans in these patient populations.
Authors: Corinde E Wiers; Falk W Lohoff; Jisoo Lee; Christine Muench; Clara Freeman; Amna Zehra; Stefano Marenco; Barbara K Lipska; Pavan K Auluck; Ningping Feng; Hui Sun; David Goldman; James M Swanson; Gene-Jack Wang; Nora D Volkow Journal: Eur J Neurosci Date: 2018-08 Impact factor: 3.386
Authors: Paul Crits-Christoph; Andrew Newberg; Nancy Wintering; Karl Ploessl; Mary Beth Connolly Gibbons; Sarah Ring-Kurtz; Robert Gallop; Julie Present Journal: Drug Alcohol Depend Date: 2008-06-20 Impact factor: 4.492
Authors: Kao Chin Chen; Yen Kuang Yang; Oliver Howes; I Hui Lee; Sabine Landau; Tzung Lieh Yeh; Nan Tsing Chiu; Po See Chen; Ru Band Lu; Anthony S David; Elvira Bramon Journal: Schizophr Bull Date: 2011-12-08 Impact factor: 9.306
Authors: Gerda Thomsen; Gitte Moos Knudsen; Peter S Jensen; Morten Ziebell; Klaus K Holst; Susanne Asenbaum; Jan Booij; Jacques Darcourt; John C Dickson; Ozlem L Kapucu; Flavio Nobili; Osama Sabri; Terez Sera; Klaus Tatsch; Livia Tossici-Bolt; Koen Van Laere; Thierry Vander Borght; Andrea Varrone; Marco Pagani; Lars Hageman Pinborg Journal: EJNMMI Res Date: 2013-05-20 Impact factor: 3.138